Expand KNSA Menu
KNSA MENU

KNSA Stock Summary and Trading Ideas (Kiniksa Pharmaceuticals Ltd. - Class A | NASDAQ:KNSA)

Charts for Today's Stock Price and Implied Volatility in Kiniksa Pharmaceuticals Ltd. - Class A

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for KNSA by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Kiniksa Pharmaceuticals Ltd. - Class A (KNSA) Frequently Asked Questions

What does Kiniksa Pharmaceuticals Ltd. - Class A do?

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

What symbol and exchange does Kiniksa Pharmaceuticals Ltd. - Class A shares trade?

Kiniksa Pharmaceuticals Ltd. - Class A trades on the NASDAQ stock market under the symbol KNSA.

What is Kiniksa Pharmaceuticals Ltd. - Class A stock price doing today?

As of March 14, 2025, KNSA stock price climbed to $22.61 with 463,179 million shares trading.

What is Kiniksa Pharmaceuticals Ltd. - Class A's Beta?

KNSA has a beta of 0.77, meaning it tends to be less sensitive to market movements. KNSA has a correlation of 0.06 to the broad based SPY ETF.

How much is Kiniksa Pharmaceuticals Ltd. - Class A worth?

KNSA has a market cap of $1.64 billion. This is considered a Small Cap stock.

How much money does Kiniksa Pharmaceuticals Ltd. - Class A make?

Last quarter Kiniksa Pharmaceuticals Ltd. - Class A reported $123 million in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-844,000 and missed earnings estimates by -$.25.

What is the highest and lowest price Kiniksa Pharmaceuticals Ltd. - Class A traded in the last 3 year period?

In the last 3 years, KNSA traded as high as $28.15 and as low as $7.36.

What are the top ETFs holding Kiniksa Pharmaceuticals Ltd. - Class A?

The top ETF exchange traded funds that KNSA belongs to (by Net Assets): IWM, VTI, VB, VBK, IWO.

Is Kiniksa Pharmaceuticals Ltd. - Class A (KNSA) a good investment?

KNSA has outperformed the market in the last year with a price return of +10.5% while the SPY ETF gained +10.4%. KNSA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.9% and +15.2%, respectively, while the SPY returned -6.5% and -3.8%, respectively.

What are the support and resistance levels for Kiniksa Pharmaceuticals Ltd. - Class A (KNSA)?

KNSA support price is $21.51 and resistance is $22.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KNSA shares will trade within this expected range on the day.